This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
Grants paid by year
Total assets by year
Where the money went · FY2025
Form 990 splits expenses into program services, management and fundraising. The split is self-reported, and a grantmaker, a research institute and a direct-service nonprofit book the same work differently. A line the return does not carry reads "not available"; it is never counted as zero.
| Year | Form | Revenue | Expenses | Grants paid | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2025 | 990 | $778,663 | $856,539 | $725,000 | $1,927,394 | $1,567,194 |
| FY2023 | 990 | $49,585 | $74,394 | $53,367 | $821,212 | $675,216 |
| FY2022 | 990 | $257,068 | $18,418 | $0 | $1,056,196 | $700,025 |
| FY2021 | 990 | $151 | $308,042 | $215,236 | $962,671 | $461,375 |
| FY2020 | 990 | $481,790 | $572,883 | $550,000 | $1,546,694 | $769,266 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
Recipient focus areas
Where recipients are
Based on the 91% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| University of Texas MD Anderson Cancer CenterHouston, TX | The purpose of the Grant is for the Principal Investigator to carry out the research to develop immune interventions that could reduce the risk of Lynch Syndrome (LS)-related cancers. The goals of the project are to develop vaccines and test their potential to prevent colorectal cancer in a preclinical model of LS and to explore the colonic immune microenvironment. | $450,000 | 2025 |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Theodora Ross | President & Chief Scientific Officer; Trustee | 5.00 | $0 |
| Howard Janzen | Board Chair; Secretary; Trustee | 5 | $0 |
| Jan Livingston-Mokhtari | Trustee | 1 | $0 |
| Douglas Hager | Trustee, Sr. Vice President, Project Management and Operations |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| University of Texas Southwestern Medical CenterDallas, TX | Scientific and administrative oversight of all Cancer Prevention Initiative programs. | $200,000 | 2023 |
| Beth Israel Deaconess Medical CenterBoston, MA | The objective of this project is to identify cancer risk predictors in the mammary epithelium of BRCA mutation carriers using state-of-the-art single cell analysis techniques. | $200,000 | 2020 |
| University of Texas Southwestern Medical CenterDallas, TX | Scientific and administrative oversight of all Cancer Prevention Initiative programs. | $180,000 | 2021 |
| Cleveland Clinic FoundationCleveland, OH | The objective of this project is to identify proteins uniquely and highly expressed in breast cancer of BRCA1 mutation carriers. Identification of these proteins can be key to developing preventative vaccines. | $150,000 | 2021 |
| Memorial Sloan Kettering Cancer CenterNew York, NY | The objective of this project is to generate a robust cellular assay that would allow for the screening of hundreds of compounds to identify determinants of Loss of Heterozygosity (LoH) of BRCA genes. LoH is a major driver in cancer initiation. | $150,000 | 2021 |
| Memorial Sloan Kettering Cancer CenterNew York, NY | This project to identify factors that influence the Loss of Heterozygosity (LOH) was initially funded in 2019. Based on the significant progress made in the project, the project was granted additional funding to continue to phase 2 in 2021 and phase 3 in 2024-2025. During phase 3, they will study allele loss under BRCA wildtype and heterozygous conditions. These studies will provide a comparative mechanistic understanding of LOH at BRCA under normal and carrier conditions. This mechanistic understanding will facilitate development of strategies to prevent LOH and thereby prevent cancer development in high-risk individuals. | $150,000 | 2025 |
| University of Texas Southwestern Medical CenterDallas, TX | Scientific and administrative oversight of all Cancer Prevention Initiative programs. | $150,000 | 2020 |
| City of HopeDuarte, CA | The objective of this project is to develop a novel approach to prevention of breast cancer that combines chemoprevention and immunoprevention of breast cancer by repurposing the FDA approved anti-parasitic drug Ivermectin. | $150,000 | 2020 |
| University of Texas Southwestern Medical CenterDallas, TX | Scientific and administrative oversight of all Cancer Prevention Initiative programs. | $125,000 | 2025 |
| Southwestern Medical FoundationDallas, TX | Grant to Southwestern Medical Foundation (SWMF) for collaborative project to pursue cancer prevention research in furtherance of the Organization's mission. | $50,000 | 2020 |
| 10 |
| $0 |
| Joi Morris | Treasurer, Trustee | 6.00 | $0 |
| Kirk Patrick | Secretary, Trustee | 0.5 | $0 |
Nearest by size, location and giving pattern in the database. Geography weighs heavily. Treat it as a starting list, not a ranking of fit.
Form 990 · FY2024 · period ending Dec 31, 2024IRS bulk XML
Filing id 202541329349304734
Form 990 · FY2023 · period ending Dec 31, 2023IRS bulk XML
Filing id 202411349349303976
Form 990 · FY2022 · period ending Dec 31, 2022
Filing id 202341249349302089
Form 990 · FY2021 · period ending Dec 31, 2021
Filing id 202221309349300807
Form 990 · FY2020 · period ending Dec 31, 2020
Filing id 202122359349301317
Form 990 · FY2018 · period ending Dec 31, 2018
Filing id 201941239349300239
Form 990 · FY2017 · period ending Dec 31, 2017
Filing id 201811359349304781
Form 990 · FY2016 · period ending Dec 31, 2016
Filing id 201701329349307180
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.